| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Actionable heterogeneity of hepatocellular carcinoma therapy-induced senescence
|
Engels, Pujan
|
|
|
74 |
7 |
|
artikel
|
| 2 |
Analyses of single-cell RNA sequencing uncover the role of intratumoral Helicobacter pylori in shaping tumor progression and immunity in gastric cancer
|
Xu, Jiao
|
|
|
74 |
7 |
|
artikel
|
| 3 |
ARHGDIB as a prognostic biomarker and modulator of the immunosuppressive microenvironment in glioma
|
Yan, Xuejun
|
|
|
74 |
7 |
|
artikel
|
| 4 |
Biomarker, efficacy and safety analysis of transcatheter arterial chemoembolization combined with atezolizumab and bevacizumab for unresectable hepatocellular carcinoma
|
Zhang, Shaobo
|
|
|
74 |
7 |
|
artikel
|
| 5 |
Cancer therapy via neoepitope-specific monoclonal antibody cocktails
|
Hartman, Colin J.
|
|
|
74 |
7 |
|
artikel
|
| 6 |
Carry-over effect of immunotherapy in patients with advanced hepatocellular carcinoma
|
Chuang, Chien-Huai
|
|
|
74 |
7 |
|
artikel
|
| 7 |
Chaperonin containing TCP1 subunit 5 as a novel pan-cancer prognostic biomarker for tumor stemness and immunotherapy response: insights from multi-omics data, integrated machine learning, and experimental validation
|
Li, Jiajun
|
|
|
74 |
7 |
|
artikel
|
| 8 |
Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapies
|
De Castro, Valentine
|
|
|
74 |
7 |
|
artikel
|
| 9 |
Clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis
|
Hazim, Antonious
|
|
|
74 |
7 |
|
artikel
|
| 10 |
Clinical, immune cell, and genetic features predicting survival and long-term response to first-line chemo-immunotherapy treatment for non-small cell lung cancer
|
Huang, Liling
|
|
|
74 |
7 |
|
artikel
|
| 11 |
Correction: Gut microbiota affects PD-L1 therapy and its mechanism in melanoma
|
Liu, Shiqi
|
|
|
74 |
7 |
|
artikel
|
| 12 |
Correction: Infectious complications distribution following CLL1 CAR-T cell therapy for acute myeloid leukemia
|
Xu, Jianmei
|
|
|
74 |
7 |
|
artikel
|
| 13 |
Correction: Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non‑small cell lung cancer based on real‑world data
|
Ramos‑Guerra, Ana D.
|
|
|
74 |
7 |
|
artikel
|
| 14 |
Correction: Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist
|
Jarosz-Biej, Magdalena
|
|
|
74 |
7 |
|
artikel
|
| 15 |
Efficacy and safety of local–regional therapy combined with chemotherapy, immune checkpoint inhibitors and lenvatinib as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study
|
Li, Shuofeng
|
|
|
74 |
7 |
|
artikel
|
| 16 |
Enhancing mesothelin CAR T cell therapy for pancreatic cancer with an oncolytic herpes virus boosting CAR target antigen expression
|
Aboalela, Mona Alhussein
|
|
|
74 |
7 |
|
artikel
|
| 17 |
Exosomal PD-L1 derived from hypoxia nasopharyngeal carcinoma cell exacerbates CD8+ T cell suppression by promoting PD-L1 upregulation in macrophages
|
Yuan, Xiaofei
|
|
|
74 |
7 |
|
artikel
|
| 18 |
Extracellular PKM2 modulates cancer immunity by regulating macrophage polarity
|
Peng, Guangda
|
|
|
74 |
7 |
|
artikel
|
| 19 |
HIF-PH inhibitors induce pseudohypoxia in T cells and suppress the growth of microsatellite stable colorectal cancer by enhancing antitumor immune responses
|
Chen, Yuehua
|
|
|
74 |
7 |
|
artikel
|
| 20 |
Immunotyping of thyroid cancer for clinical outcomes and implications
|
Xu, Jin
|
|
|
74 |
7 |
|
artikel
|
| 21 |
Impact of innate lymphoid cell type 2 in chronic lymphocytic leukemia on the function of treg and CD8+ T cells through IL-9
|
Yang, Ruixue
|
|
|
74 |
7 |
|
artikel
|
| 22 |
Impact of rheumatoid factors on the function of therapeutic monoclonals specific for PD-1/PD-L1
|
Hock, Barry D.
|
|
|
74 |
7 |
|
artikel
|
| 23 |
Improved efficacy of concurrent anti-PD1 antibody plus AVD versus ABVD in patients with newly diagnosed early unfavorable and advanced stage classic Hodgkin lymphoma: a retrospective matched cohort study
|
Wu, Mengqiu
|
|
|
74 |
7 |
|
artikel
|
| 24 |
Inhibition of head and neck squamous cell carcinoma by Bruton’s tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells
|
Bopp, Anna R.
|
|
|
74 |
7 |
|
artikel
|
| 25 |
KLF12 as a potential biomarker for lateral pelvic lymph node metastases in advanced rectal cancer
|
Xiao, Tianxian
|
|
|
74 |
7 |
|
artikel
|
| 26 |
KLRG1 expression induces functional exhaustion of NK cells in colorectal cancer patients
|
Xu, Cairui
|
|
|
74 |
7 |
|
artikel
|
| 27 |
Knockdown NEK7 stimulates anti-tumor immune responses by NLRP3/PD-L1 signaling in esophageal cancer
|
Wang, Li
|
|
|
74 |
7 |
|
artikel
|
| 28 |
LAG3 as a marker of immune activation in esophageal squamous carcinoma treated with concurrent chemoradiotherapy
|
Zhang, Yuxuan
|
|
|
74 |
7 |
|
artikel
|
| 29 |
Mast cells-intestinal cancer cells crosstalk is mediated by TNF-alpha and sustained by the IL-33/ST2 axis
|
Dal Secco, Chiara
|
|
|
74 |
7 |
|
artikel
|
| 30 |
Molecular mimicry between parasites and cancer: a novel approach for developing cancer vaccines and therapeutic antibodies
|
Eissa, Maha Mohamed
|
|
|
74 |
7 |
|
artikel
|
| 31 |
Molecular subtyping dictates therapeutic response to anti-PD-L1 immunotherapy in ES-SCLC
|
Zhang, Qianqian
|
|
|
74 |
7 |
|
artikel
|
| 32 |
NECTIN4 regulates the cell surface expression of CD155 in non-small cell lung cancer cells and induces tumor resistance to PD-1 inhibitors
|
Mizusaki, Shun
|
|
|
74 |
7 |
|
artikel
|
| 33 |
Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic cancer models
|
Pakola, Santeri A.
|
|
|
74 |
7 |
|
artikel
|
| 34 |
Osteosarcoma cell–derived CCL2 facilitates lung metastasis via accumulation of tumor-associated macrophages
|
Kondo, Hiroya
|
|
|
74 |
7 |
|
artikel
|
| 35 |
Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)
|
Santoni, Matteo
|
|
|
74 |
7 |
|
artikel
|
| 36 |
Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study
|
Porta, Camillo
|
|
|
74 |
7 |
|
artikel
|
| 37 |
Predictive factors and nomogram for the risk of cytokine release syndrome with anti-CD3 × CD20 bispecific antibodies for Chinese patients
|
Sun, Peng
|
|
|
74 |
7 |
|
artikel
|
| 38 |
Prognostic significance of osteosarcopenia and its effects on immune response in patients with stage II/III gastric cancer
|
Hirase, Yuki
|
|
|
74 |
7 |
|
artikel
|
| 39 |
Recombinant antibodies from clonally expanded cancer-associated plasma cells
|
Kim, Wonkyung
|
|
|
74 |
7 |
|
artikel
|
| 40 |
Single-cell RNA sequencing analysis reveals a lack of CXCL13+ T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy
|
Li, Xia
|
|
|
74 |
7 |
|
artikel
|
| 41 |
Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade
|
Wu, Yirong
|
|
|
74 |
7 |
|
artikel
|
| 42 |
Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy
|
Reischer, Anna
|
|
|
74 |
7 |
|
artikel
|
| 43 |
The combination of SH003 and DTX induces cytotoxic cell infiltration in anti-PD1 resistant lung cancer
|
Choi, Yu-Jeong
|
|
|
74 |
7 |
|
artikel
|
| 44 |
Transarterial chemoembolization combined with tyrosine kinase inhibitors and/or immune checkpoint inhibitors induced hypothyroidism is associated with improved overall survival in hepatocellular carcinoma
|
Xu, Shengyuan
|
|
|
74 |
7 |
|
artikel
|
| 45 |
Unraveling the complex role of tumor-associated neutrophils within solid tumors
|
Wang, Yingxin
|
|
|
74 |
7 |
|
artikel
|
Tijdschrift beschrijving